TNFRSF11A and neoplasm: • Inhibiting metastasis and tumor progression with minimal side effects such as bone loss• Inhibiting the RANK/RANKL pathway• Inhibiting the interaction between tumor cells and the BME components• Balancing the activity of osteoblasts and osteoclasts